Legend Biotech Corp (LEGN) SEC Filings — 2025

Filings

• Legend Biotech Corp 6-K Filing — 6-K · Dec 8, 2025
• Legend Biotech Files 6-K with Q3 2025 Financials — 6-K · Nov 12, 2025
• Legend Biotech Files 6-K Report — 6-K · Nov 3, 2025
• Legend Biotech CARVYKTI® Sales Hit $524M — 6-K · Oct 14, 2025
• Legend Biotech & Janssen Ink Supply Deal — 6-K · Oct 7, 2025
• Legend Biotech Files 6-K, Confirms 20-F Reporting — 6-K · Aug 18, 2025
• Legend Biotech Files 6-K with Q2 2025 Financials — 6-K · Aug 11, 2025
• Legend Biotech CARVYKTI® Sales Hit $439M in Q2 2025 — 6-K · Jul 16, 2025
• Legend Biotech CAR T Therapies REMS Removed by FDA — 6-K · Jun 30, 2025
• Legend Biotech Files 2025 Annual Meeting Voting Results — 6-K · Jun 12, 2025
• Legend Biotech Updates Corporate Presentation — 6-K · Jun 6, 2025
• Legend Biotech Appoints Yale's Peter Salovey Lead Independent Director — 6-K · Jun 5, 2025
• Legend Biotech Files 6-K Report — 6-K · Jun 3, 2025
• Legend Biotech Files 6-K Report — 6-K · May 23, 2025
• Legend Biotech Leases New HQ in Bridgewater, NJ — 6-K · May 14, 2025
• Legend Biotech Files Q1 2025 6-K with Financial Data — 6-K · May 13, 2025
• Legend Biotech Sets Annual Shareholder Meeting for June 12 — 6-K · May 12, 2025
• Legend Biotech CARVYKTI® Sales Hit $369M — 6-K · Apr 15, 2025
• Legend Biotech Files 6-K Report — 6-K · Mar 11, 2025
• Legend Biotech Files 20-F for FY2024 — 20-F · Mar 11, 2025
• Legend Biotech CARVYKTI Sales Hit $334M — 6-K · Jan 22, 2025
• Legend Biotech Updates Presentation for J.P. Morgan Conference — 6-K · Jan 14, 2025